Intravenous and intra-arterial oxygen-15-labeled water and fluorine-18- labeled fluorouracil in patients with liver metastases from colorectal carcinoma

Journal of Nuclear Medicine

Volumn 39, Issue 3, 1998, Pages 465-473

  Dimitrakopoulou Strauss, Antonia ^a   Strauss, Ludwig G ^b   Schlag, Peter ^b   Hohenberger, Peter ^b   Irngartinger, Gisela ^b   Oberdorfer, Franz ^b   Doll, Josef ^b   Van Kaick, Gerhard ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NONE

Author keywords

Fluorine 18 fluorouracil; Liver metastases; Oxygen 15 water; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; OXYGEN 15; TRACER;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLUSTER ANALYSIS; COLORECTAL CARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; LIVER METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT PLANNING;

ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; FLUOROURACIL; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; LIVER NEOPLASMS; OXYGEN RADIOISOTOPES; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; WATER;

EID: 0031905825     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Strauss LG, Clorius JH, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989;170:329-332.
2. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-648.
3. Dimitrakopoulou A, Strauss LG, Clorius JH, et al. Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma. J Nucl Med 1993;34:1075-1081.
4. Kemeny N. The systemic chemotherapy of hepatic metastases. Semin Oncol 1983;10: 148-158.
5. Niederhuber JE, Ensminger WD. Surgical consideration in the management of hepatic neoplasia. Semin Oncol 1983;10:135-147.
6. Vaughn DJ, Haller DG. Nonsurgical management of recurrent colorectal cancer. Cancer 1993;71:4278-4292.
7. Boyle FM, Smith RC, Levi JA. Continuous hepatic artery infusion of 5-fluorouracil for metastatic colorectal cancer localised to the liver. Aust N Z J Med 1993;23:32-34.
8. De Takats PG, Kerr DJ, Poole CJ, et al. Hepatic arterial chemotherapy for metastatic colorectal carcinoma. Br J Cancer 1994;69:372-378.
9. Del Fiore F, Depresseux JC, Bartsch P, Quaglia L, Peters JM. Production of oxygen-15, nitrogen-13 and carbon-31 and of their low molecular weight derivatives for biomedical applications. Int J Appl Radiat Isot 1979;30:5443-5449.
10. Oberdorfer F, Hofmann E, Maier-Borst W. Preparation of 18-F-labeled 5-fluorouracil of very high purity. J Label Compd Radiopharm 1989;27:137-145.
11. Doll J, Ostertag HJ, Bellemann ME, et al. Effects of distorted PET projection data on the reconstructed image using different reconstruction algorithms. In: Bergmann H, Sinzinger H, eds. Radioactive isotopes in clinical medicine and research advances in pharmacological sciences. Basel: Birkhäuser Verlag; 1995:85-90.
12. Hoverath H, Kübler WK, Ostertag H, et al. Scatter correction in the transaxial slices of a whole-body positron emission tomograph. Phys Med Biol 1993;38:717-728.
13. Ostertag H, Kübler WK, Doll J, Lorenz WJ. Measured attenuation correction methods. Eur J Nucl Med 1989;15:722-726.
14. Ziessman HA, Thrall JH, Gyves JW, et al. Quantitative hepatic arterial perfusion scintigraphy and starch microspheres in cancer chemotherapy. J Nucl Med 1983;24: 871-875.
15. Kaplan WD, Jaroszweski J, Clarke R, et al. Radionuclide angiography to predict patient response to hepatic artery chemotherapy. Cancer Treat Rep 1980;64:1217-1222.
16. Lehner B, Kretzschmar U, Bubeck B, et al. Results of liver angiography and perfusion scintigraphy do not correlate with response to hepatic artery infusion chemotherapy. J Surg Oncol 1988;39:73-78.
17. 15O. I. Theory and error analysis. J Nucl Med 1983;24:782-789.
18. Collins J. Pharmacologic rationale for regional drug delivery (review). J Clin Oncol 1984;2:498-504.
19. Bledin AG, Kim EE, Chuang VP, et al. Changes of arterial blood flow patterns during infusion chemotherapy, as monitored by intra-arterially injected technetium-99m macroaggregated albumin. Br J Radiol 1984;57:197-203.
20. Dimitrakopoulou A, Strauss LG, Knopp MV, et al. Positron emission tomography measurement of fluorouracil uptake prior to therapy and chemotherapy response. In: Breit A, Heuck A, Lukas P, Kneschaurek P, Mayr M, eds. Tumor response monitoring and treatment planning, 1st ed. Berlin: Springer-Verlag; 1992:219-222.
21. Strauss LG. Application of positron emission tomography in colorectal carcinoma. Onkologie 1993;16:232-244.
22. Chaudhuri NK, Murkherjee KL, Heidelberger C. Studies of fluorinated pyrimidines-VII-the degradative pathway. Biochem Pharmacol 1959;1:328-341.
23. 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits. Proc Natl Acad Sci USA 1990;87:492-496.
24. 18fluorouracil in sensitive versus resistant lymphocytic leukemia in mice. Cancer Res 1977;37:2306-2308.
25. Semmler W, Bachert-Baumann P, Gückel F, et al. Real-time follow-up of 5-fluorouracil metabolism in the liver of tumor patients by means of F-19 MR spectroscopy. Radiology 1990;174:141-145.
26. Sela S, Husain SR, Pearson JW, et al. Reversal of multidrug resistance in human colon cancer cells expressing the human MDRI gene by liposomes in combination with monoclonal antibody or verapamil. J Natl Cancer Inst 1995;87:123-128.
27. Wohlhueter RM, McIvor RS, Plagemann PGW. Facilitated transport of uracil and 5-fluorouracil, and permeation of orotic acid into cultured mammalian cells. J Cell Physiol 1980;104:309-319.
28. Jacquez JA. Permeability of Ehrlich cells to uracil, thymine and fluorouracil. Proc Soc Exp Biol Med 1962;109:132-135.
29. Yamamoto S, Kawasaki T. Active transport of 5-fluorouracil and its energy coupling in Ehrlich ascites tumor cells. J Biochem 1981;90:635-642.
30. Domin BA, Mahony WB, Zimmerman TP. Transport of 5-fluorouracil and uracil into human erythrocytes. Biochem Pharmacol 1993;46:503-510.